About this episode

This episode discusses the lack of effective therapies for preserving kidney function in patients with sickle cell disease and the findings related to RAS inhibitors.

Sickle cell disease causes accelerated kidney function decline, yet proven GFR-preserving therapies remain elusive. In this study of adults with sickle cell disease, RASi use was not associated with a significant difference in the rate of eGFR decline.

Topics covered

• kidney function
• sickle cell disease
• eGFR decline
• RAS inhibitors
• healthcare research

Keywords

• kidney function
• sickle cell disease
• eGFR
• Renin Angiotensin System Inhibitors
• health research

Mentioned in this episode

Organizations: American Society of Nephrology

Products: Renin Angiotensin System Inhibitors

Explore listener stats, chart rankings, contacts and more on the Kidney360 podcast page.